Adaptive Pharmacogenomics, LLC

Partnership to address increasing demand for protein biomarker testing in pharmaceutical research and development in the Chinese market

BEIJING, China. , (November 30, 2010) – Aushon BioSystems, Inc. , a leading provider of multiplex immunoassay products and services for biomarker discovery, development and analysis announced during the ChinaTrials 2010 Summit in Beijing, China, that it has entered into a partnership with LightArray Biotech Company, Ltd.

In a new report "Public health in an era of genomic and personalized medicine," experts in medicine, law, bioethics, public health, and genetics have identified key issues for the future of global public health in light of rapid developments in genomic medicine and associated technologies.

Researchers at the University of Pennsylvania School of Medicine’s Udall Center for Parkinson's Research have developed the first blood-based biomarker test to predict cognitive decline in Parkinson’s disease (PD). If results can be replicated and standardized in other Parkinson patients, by other investigators, the test could be a useful tool to use in selecting patients for the development of new drugs that can slow or prevent this complication of the disease.

Aushon BioSystems, Inc. , a leading provider of advanced microarray products and laboratory services for biomarker discovery, development and analysis, announces that Sven Beushausen, Ph. D. , has been appointed to the position of Chief Scientific Officer. Dr.

( from http://www. rxpgnews. com ) AURORA, Colo. (Nov. 16, 2010) A clinical trial that aims to speed up the study of new treatments for certain subtypes of breast cancer now has a designated study site at the Diane O'Connor Thompson Breast Center at the University of Colorado Hospital.

From genomic landscapes to personalized cancer management-is there a roadmap?

The molecular principles of N-end rule recognition.

[Current topics and problems in toxicology laboratories--8: paradigm shift in clinical toxicological analysis].

Genetics for the pediatric anesthesiologist: a primer on congenital malformations, pharmacogenetics, and proteomics.

The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.